Add Company
Join Now

Kalyagen Revenue and Competitors

License our Company Data API

Austin, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kalyagen's estimated annual revenue is currently $620k per year.(i)
  • Kalyagen's estimated revenue per employee is $155,000

Employee Data

  • Kalyagen has 4 Employees.(i)
  • Kalyagen grew their employee count by -43% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Kalyagen?

The development of Kalyagen started nearly 25 years ago when Christian Drapeau began studying the aquatic botanical Aphanizomenon flos-aquae (AFA). People consuming AFA reported benefits touching three main aspects of human health: immune and inflammation support, and an increase in mental clarity and energy. In 2016, Drapeau used his accrued years of research and development, having investigated an extensive variety of plants, to develop Stemregen. Kalyagen has been created to market Stemregen and to continue the effort of researching plants coming from remote areas that have unique health properties. STEMREGEN® is a unique proprietary blend of plant-based extracts documented to support endogenous stem cell mobilization (ESCM). Although STEMREGEN® is safe for long-term use and does not require prescription, it has been developed specifically for doctors interested in working with the concept of ESCM.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$620k

Revenue (est)

-43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M40%$103M
#2
$0.3M4N/AN/A
#3
$0.3M4N/AN/A
#4
$0.3M4N/AN/A
#5
$0.4M4N/AN/A